AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KOCT 282 min read$AVTR

Avantor® Reports Third Quarter 2026 Results

Avantor, Inc. (AVTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Avantor® Reports Third Quarter 2026 Results • Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2% • Diluted GAAP EPS of $0.30; adjusted EPS of $0.22 • Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow guidance RADNOR, Pa. –

Original reporting
SEC EDGAR 8-K
Published Oct 28, 2026, 10:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$AVTR
Bullish
high confidence
Mentioned
$AVTR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AVTRBullishHigh
01

Why it matters

The earnings beat and updated guidance provide fresh data that can influence short‑term trading decisions.

02

Market read

The new earnings and guidance data are material for AVTR and may affect related sector stocks.

03

What to watch

Potential headwinds from foreign‑currency translation and higher SG&A could temper earnings momentum.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Avantor is a leading provider of life‑science and advanced‑technology products, reporting its quarterly performance via an SEC Form 8‑K.

Company-level read

Ticker impact

$AVTRBullishHigh confidence
Context

Avantor reported Q3 2026 results and issued updated FY 2026 guidance, including raised organic revenue growth and free cash flow targets.

Expected impact

likely upward pressure as investors price in the updated guidance

Evidence & confidence

The earnings beat and the upward‑adjusted guidance provide fresh, material information that can move the stock in the short term.

Market effects

Sector

Life‑science tools sector may see broader optimism from Avantor's results.

Regional

U.S. markets may see a modest lift in related biotech and specialty chemicals stocks.

Global

Limited to investors tracking global life‑science supply chains.

Counterpoint

What could challenge this read

If the guidance uplift is modest, the market may have already priced it in, limiting upside.

Key entities

  • company
    Avantor, Inc.

    Issuer of the earnings release and guidance update.

Read at source← All news

StoryAvantor posts Q3 profit, lifts FY 2026 revenue and EPS guidance

Also covered by

5 outlets

Related articles

OCT 28
$AVTRMedAI 8/10

Avantor beats Q3 estimates but shares slip on guidance

Avantor Inc. (NYSE: AVTR) reported Q3 adjusted EPS of $0.22, beating estimates by $0.01, with revenue of $1.70B, up 4.6% YoY. Shares fell 2.6% as guidance matched expectations. The company raised its full-year organic revenue growth and free cash flow outlooks. Organic revenue grew 5.2% YoY, with segments showing varied performance.

investing.com2 min
OCT 28
$AVTRMedAI 8/10

Avantor (NYSE:AVTR) reports upbeat Q3 2026

Avantor (AVTR) reported Q3 2026 revenue of $1.70B, beating estimates by 3.4% YoY. Adjusted EPS was $0.22, a 5.6% beat. Adjusted EBITDA was $256.9M, a 2.6% beat. Management raised full-year EPS guidance to $0.82. Operating margin improved to 8.2%, while free cash flow margin decreased to 9.2%. Organic revenue grew 5.2% YoY.

finance.yahoo.com2 min